New method for the analysis of intestinal bacteria

Prospects for personalized medicine in Crohn’s disease

1 Min
More

Future Tech Days @ Charité BIH Innovation - Pitching opportunity for digital health startups

The Charité BIH Innovation team established a new event series to expand the matching and connecting activities and to create a broader platform: The Future Tech Days – where digital health startups and members of Charité meet for a short pitch…

1 Min
More

Eckert & Ziegler Signs Licence Agreement for Actinium-225 with Chinese Joint Venture

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…

1 Min
More

EIB provides €35 million to Formo to expand production of cheese alternatives free from animal products

- Berlin-based food tech company Formo develops fermentation processes to produce cheese alternatives.

- The €35 million EIB investment is backed by the European Union's InvestEU guarantee.

- This venture debt loan brings Formo’s total financing to…

4 Min
More

Aignostics Announces Results for Pathology Foundation Model Developed in Collaboration with Mayo Clinic

Model was generated in only two months and sets new industry standard for performance

3 Min
More

Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TAMUC1 Antibody in DS-3939 from Glycotope GmbH

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab.

3 Min
More

Developing a CRISPR therapy for muscular dystrophy

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves…

4 Min
More

ProBioGen Expands Protein and Viral Manufacturing to Drive Continued Growth

ProBioGen today announces the expansion of both protein and virus manufacturing at its Berlin headquarters. This includes the commissioning of an additional 1000L-scale GMP production line for proteins as well as the completion of the construction…

3 Min
More

Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW

Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), a leading provider of isotope technology for nuclear medicine and radiopharmaceutical applications, announces the submission of its GalliaPharm® 68Ge/68Ga Radionuclide Generator for approval in…

2 Min
More
Show more items